Author(s): Anju govind, Manjunath B Menden, Ravikumar, Simila1, Mercy, Narayana Swamy VB

Email(s): ravikumar300@gmail.com

DOI: 10.5958/2231-5713.2016.00013.1   

Address: Anju govind1, Manjunath B Menden2, Ravikumar2*, Simila1, Mercy1, Narayana Swamy VB3
1M.Pharam (Pharmaceutics) Research Scholar, Karavli College of Pharmacy, Mangalore.
2Department of Pharmaceutics, Karavali College of Pharmacy, Vamanjoor, Mangalore.
3Department of Pharmacognosy, Karavali College of Pharmacy, Vamanjoor, Mangalore.
*Corresponding Author

Published In:   Volume - 6,      Issue - 2,     Year - 2016


ABSTRACT:
The present investigation of research is oriented through increasing safety and efficacy of existing drug molecule through novel concept of oral drug delivery Deflazacort is a synthetic steroid that has an anti inflammatory effect. It is used to decrease inflammation in various different diseases and conditions. Deflazacort works by acting within cells to prevent the release of certain chemicals that are important in the immune system. These chemicals are normally involved in producing immune and allergic responses; resulting in inflammation. By decreasing the release of these chemicals in a particular area, inflammation is reduced. This can help control a wide number of disease states characterized by excessive inflammation. These include severe allergic reactions, inflammation of the lungs in asthma and inflammation of the joints in arthritis. Deflazacort also decreases the numbers of white blood cells circulating in the blood. And patients Nephritic Syndrome, required steroids for long times. Mouth dissolving tablets of Deflazacort were prepared by Superdisintegrant addition method using SSG, and Croscarmellose sodium as superdisintegrants at 5-10% w/w, showed minimum time to disintegrate the tablet (20.13 sec.) and almost complete release of drug within 15 minutes. The optimized formulation F14 was chosen and their optimum results were found to be in close agreement with experimental finding. The FTIR studies for the optimized formulation F14 shows that there was no interaction between drug and excipients. The stability studies for the optimized formulation F14 showed no significant changes.


Cite this article:
Anju govind, Manjunath B Menden, Ravikumar, Simila1, Mercy, Narayana Swamy VB. Formulation and Evaluation of Mouth Dissolving Tablets of Deflazacort. Asian J. Pharm. Tech. 2016; 6(2): 91-98. doi: 10.5958/2231-5713.2016.00013.1


Recomonded Articles:

Author(s): Hafsa, Asfa, Nuha Rasheed, Abdul Saleem Mohammad

DOI: 10.5958/2231-5713.2017.00001.0         Access: Open Access Read More

Author(s): Yogita. Chowdhary

DOI: 10.5958/2231-5713.2018.00002.8         Access: Open Access Read More

Author(s): Anju govind, Manjunath B Menden, Ravikumar, Simila1, Mercy, Narayana Swamy VB

DOI: 10.5958/2231-5713.2016.00013.1         Access: Open Access Read More

Author(s): Nirmala Rangu, B. Chaitanya Kumari, Ganesh Akula, A Jaswanth

DOI: 10.5958/2231-5713.2018.00001.6         Access: Open Access Read More

Author(s): Rohan Patil, Neha Patil, Aniket Patil , S. J. Shid, V.N. Dange, C.S. Magdum, S.K. Mohite

DOI: 10.5958/2231-5713.2016.00026.X         Access: Open Access Read More

Author(s): Chinmaya Keshari Sahoo, Surepalli Ram Mohan Rao, Muvvala Sudhakar, D. Venkata Ramana, K.Satyanarayana

DOI: 10.5958/2231-5713.2018.00003.X         Access: Open Access Read More

Author(s): Neha Srivastava, Seema Thakur, Anchal Bajaj, Nikita Sahi

DOI:         Access: Open Access Read More

Author(s): Pawar P.B., M.P. Wagh, S.N. Bhandare

DOI:         Access: Open Access Read More

Author(s): S. Kumara Swamy, G. Arun, Bethi Srinivas, Agaiah Goud B

DOI: 10.5958/2231-5713.2016.00014.3         Access: Open Access Read More

Author(s): Vaishali B. Morade, Vandana R. Daga, Dr. Prashant R. Malpure

DOI: DOI: 10.5958/2231-5713.2018.00006.5         Access: Open Access Read More

Author(s): Chinmaya Keshari Sahoo, K. Satyanarayana, D. Venkata Ramana, Kanhu Charan Panda

DOI: 10.5958/2231-5713.2017.00034.4         Access: Open Access Read More

Author(s): Sarfaraz Md., Arshad Ahmed Khan K., Doddayya H., Reddy S.R. , Udupi R.H.

DOI:         Access: Open Access Read More

Author(s): B. Ranga Nayakulu, Nakka Ravi Kumar, Ch. Kiran Kumar, P. Raja Abhilash

DOI: 10.5958/2231-5713.2016.00012.X         Access: Open Access Read More

Author(s): Raut Indrayani D, Gharge Manisha, Dandwde Sonli, Mohite S.K., Magdum C.S.

DOI: 10.5958/2231-5713.2017.00008.3         Access: Open Access Read More

Author(s): Yogita Rayate, Shrinivas Mohite, Shital Shewale, Aishwarya Patil

DOI: 10.5958/2231-5713.2019.00005.9         Access: Closed Access Read More

Author(s): Himanshu Deshmkh, Chandrashekhara S., Nagesh C., Amol Murade, Shridhar Usgaunkar.

DOI:         Access: Open Access Read More

Author(s): Sampada V. Kadam, Nilima U. Rane, Chandrakant S. Magdum

DOI: 10.5958/2231-5713.2019.00011.4         Access: Closed Access Read More

Author(s): V. S. Aher, B. A. Bhairav, R. B. Saudagar

DOI: 10.5958/2231-5713.2016.00031.3         Access: Open Access Read More

Author(s): V Jhansipriya Marabathuni, M. Bhavani, M. Lavanya, K. Padmaja, N. Madhavi, P. Babu, Ch. M. M. Prasada Rao

DOI: 10.5958/2231-5713.2017.00022.8         Access: Open Access Read More

Asian Journal of Pharmacy and Technology (AJPTech.) is an international, peer-reviewed journal, devoted to pharmaceutical sciences...... Read more >>>

RNI: Not Available                     
DOI: 10.5958/2231–5713 


Recent Articles




Tags